UBS Group’s Vigil Neuroscience VIGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-302,468
| Closed | -$2.4M | – | 10973 |
|
|
2025
Q2 | $2.4M | Buy |
302,468
+302,302
| +182,110% | +$1.36M | ﹤0.01% | 4625 |
|
|
2025
Q1 | $295 | Buy |
166
+165
| +16,500% | +$370 | ﹤0.01% | 9845 |
|
|
2024
Q4 | $2 | Sell |
1
-282
| -100% | -$833 | ﹤0.01% | 9856 |
|
|
2024
Q3 | $962 | Sell |
283
-4,525
| -94% | -$16.8K | ﹤0.01% | 8763 |
|
|
2024
Q2 | $19.2K | Sell |
4,808
-11,343
| -70% | -$38.8K | ﹤0.01% | 7330 |
|
|
2024
Q1 | $55.1K | Buy |
+16,151
| New | +$50.4K | ﹤0.01% | 6469 |
|
|
2023
Q2 | – | Sell |
-592
| Closed | -$5.8K | – | 9702 |
|
|
2023
Q1 | $5.8K | Buy |
592
+82
| +16% | +$922 | ﹤0.01% | 7986 |
|
|
2022
Q4 | $6.38K | Buy |
+510
| New | +$6.26K | ﹤0.01% | 9040 |
|
|
2022
Q3 | – | Sell |
-2,448
| Closed | -$6K | – | 10972 |
|
|
2022
Q2 | $6K | Buy |
2,448
+1,528
| +166% | +$6.04K | ﹤0.01% | 8730 |
|
|
2022
Q1 | $6K | Buy |
+920
| New | +$12.1K | ﹤0.01% | 9002 |
|
